Carl Zeiss Meditec AG
Berlin, 10589, Germany
NCT Number: NCT01731743
The purpose of the study is to evaluate the far, intermediate and near visual acuities with a trifocal IOL.
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Berlin, 10589, Germany
After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm) and near (40 cm) distance as well as the subjective refraction.
A patient questionnaire will be used to assess the patient satisfaction and spectacle independence.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 3 months postoperatively
Monocular and binocular uncorrected and best distance corrected
Time frame: 1 and 3 month postoperatively
Monocular and binocular uncorrected and best distance corrected
Time frame: 1 and 3 month postoperatively
Carl Zeiss Meditec AG
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06264830
Cataract, Eye Diseases
Taipei, Taiwan
View Trial DetailsNCT07767643
Anxiety, Anxiety Disorders
Yatağan, Muğla, Turkey (Türkiye)
View Trial DetailsNCT06555770
Anxiety Disorders, Cataract
Samsun, Turkey (Türkiye)
View Trial DetailsNCT06611670
Cataract, Cataract Bilateral
Montreal, Quebec, Canada
View Trial Details